Incidence of BK Virus in HIV-positive Kidney Transplant Recipients: Case Series From South Africa

Résumé fourni par la source

Background: BK virus-associated nephropathy (BKVN) is a viral complication after kidney transplantation and an important cause of graft dysfunction and loss. Its impact on HIV-positive kidney transplant recipients (KTRs), who are at increased risk for opportunistic infections, remains poorly understood. Methods: This single-center case series in South Africa describes BKVN incidence and outcomes in HIV-positive KTRs who received kidneys from HIV-positive donors between 2008 and 2025. A screening protocol and schedule were implemented in 2021, and BKVN was classified as possible, probable, or presumptive according to The Second International Consensus Guidelines. Results: , and all KTRs had suppressed HIV viral load on antiretroviral therapy. HIV-associated nephropathy was the most common cause of end-stage kidney disease. Hypertension was prevalent (89%), and one-third had a history of treated tuberculosis. All patients received antithymocyte globulin induction at transplant. Seventeen recipients had no BKVN screening data, 36 maintained negative BK viral loads, while 8 developed BK polyomavirus viremia and/or viruria. Of these, 2 (3%) had polymerase chain reaction-confirmed viremia, and 6 (10%) met criteria for possible (n = 1), probable (n = 2), or presumptive BKVN (n = 3). BK polyomavirus viremia and/or viruria occurred either within 6 mo or between 1 and 2 y posttransplant. Management consisted of reducing immunosuppression. Possible and probable cases (5%) maintained functioning grafts. All 3 (5%) presumptive cases had biopsy-proven disease, with one resulting in graft loss (1.6%). Conclusions: Despite limited resources and delayed routine screening, the BKVN incidence was low (5%), and most affected recipients achieved viral control and preserved graft function.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.